1. Home
  2. GBIO vs RMTI Comparison

GBIO vs RMTI Comparison

Compare GBIO & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • RMTI
  • Stock Information
  • Founded
  • GBIO 2016
  • RMTI 1994
  • Country
  • GBIO United States
  • RMTI United States
  • Employees
  • GBIO N/A
  • RMTI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • RMTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GBIO Health Care
  • RMTI Health Care
  • Exchange
  • GBIO Nasdaq
  • RMTI Nasdaq
  • Market Cap
  • GBIO 29.5M
  • RMTI 32.5M
  • IPO Year
  • GBIO 2020
  • RMTI 1998
  • Fundamental
  • Price
  • GBIO $4.51
  • RMTI $0.98
  • Analyst Decision
  • GBIO Strong Buy
  • RMTI Strong Buy
  • Analyst Count
  • GBIO 4
  • RMTI 2
  • Target Price
  • GBIO $73.33
  • RMTI $4.00
  • AVG Volume (30 Days)
  • GBIO 206.6K
  • RMTI 449.6K
  • Earning Date
  • GBIO 08-06-2025
  • RMTI 08-14-2025
  • Dividend Yield
  • GBIO N/A
  • RMTI N/A
  • EPS Growth
  • GBIO N/A
  • RMTI N/A
  • EPS
  • GBIO N/A
  • RMTI N/A
  • Revenue
  • GBIO $24,556,000.00
  • RMTI $97,727,000.00
  • Revenue This Year
  • GBIO N/A
  • RMTI N/A
  • Revenue Next Year
  • GBIO N/A
  • RMTI $11.16
  • P/E Ratio
  • GBIO N/A
  • RMTI N/A
  • Revenue Growth
  • GBIO 146.47
  • RMTI 12.82
  • 52 Week Low
  • GBIO $3.00
  • RMTI $0.78
  • 52 Week High
  • GBIO $34.35
  • RMTI $5.15
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 54.72
  • RMTI 44.49
  • Support Level
  • GBIO $4.05
  • RMTI $1.08
  • Resistance Level
  • GBIO $5.10
  • RMTI $1.18
  • Average True Range (ATR)
  • GBIO 0.63
  • RMTI 0.09
  • MACD
  • GBIO 0.02
  • RMTI -0.01
  • Stochastic Oscillator
  • GBIO 35.65
  • RMTI 5.71

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Share on Social Networks: